1193389-40-0 Usage
Uses
Used in Pharmaceutical Research and Development:
1-(4-BROMOPHENYL)CYCLOBUTANAMINE (HYDROCHLORIDE) is used as a chemical intermediate for the synthesis of potential drugs and therapeutic agents. Its unique structure and properties make it a valuable component in the creation of new pharmaceutical compounds aimed at treating various medical conditions.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 1-(4-BROMOPHENYL)CYCLOBUTANAMINE (HYDROCHLORIDE) is used as a building block for designing and optimizing new molecules with specific biological activities. Its bromophenyl group can be further modified or used in combination with other functional groups to create novel drug candidates with improved efficacy and selectivity.
Used in Drug Discovery:
1-(4-BROMOPHENYL)CYCLOBUTANAMINE (HYDROCHLORIDE) is employed in drug discovery processes to identify and develop new chemical entities with potential therapeutic benefits. Its presence in compound libraries allows researchers to screen and evaluate its biological activity against various targets, leading to the discovery of new drugs for the treatment of different diseases.
Used in Clinical Settings:
As the hydrochloride salt form of 1-(4-BROMOPHENYL)CYCLOBUTANAMINE, 1-(4-BROMOPHENYL)CYCLOBUTANAMINE (HYDROCHLORIDE) is water-soluble, making it suitable for administration in clinical settings. It can be used as a pharmaceutical agent for the treatment of specific medical conditions, once its safety, efficacy, and pharmacokinetic properties have been thoroughly evaluated and approved.
Check Digit Verification of cas no
The CAS Registry Mumber 1193389-40-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,3,3,8 and 9 respectively; the second part has 2 digits, 4 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 1193389-40:
(9*1)+(8*1)+(7*9)+(6*3)+(5*3)+(4*8)+(3*9)+(2*4)+(1*0)=180
180 % 10 = 0
So 1193389-40-0 is a valid CAS Registry Number.
1193389-40-0Relevant academic research and scientific papers
Synthesis method of arylcyclobutane compound
-
Paragraph 0206-0208; 0221-0224, (2022/01/10)
The present invention discloses a method for synthesizing an arylcyclobutane compound to 1eq phenylacetonitrile and 1.1eq 1-bromo-3-chloropropane as raw material, N,N- dimethylacetamide as a solvent, plus 2.5eq sodium hydride, under the protection of iner
Oxadiazole Amine Derivative Compounds as Histone Deacetylase 6 Inhibitor, and the Pharmaceutical Composition Comprising the same
-
Paragraph 1332; 1339-11341, (2017/07/18)
The present invention relates to a novel compound having an activity of inhibiting histone deacetylase 6 (HDAC6), an optical isomer thereof or a pharmaceutically acceptable salt thereof, a use thereof for preparation of a drug for treatment, a pharmaceutical composition comprising the same, a treatment method using the composition, and a method for preparing the same. The novel compound, an optical isomer thereof or a pharmaceutically acceptable salt thereof according to the present invention has an activity of inhibiting histone deacetylase 6 (HDAC6), and is effective for preventing or treating HDAC6-related diseases, including infectious diseases; neoplasm; endocrine, nutritional and metabolic diseases; mental and behavior disorders; nerve disorders; eye and adnexa diseases; cardiovascular diseases; respiratory diseases; digestive organ diseases; skin and subcutaneous tissue diseases; musculoskeletal and connective tissue diseases; or congenital malformation, deformation and chromosomal abnormality.COPYRIGHT KIPO 2017
